delta-tocopherol has been researched along with Cell Transformation, Neoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bak, MJ; Cai, L; Das Gupta, S; Lee, MJ; Lin, Y; Patel, M; Shih, WJ; Suh, N; Wahler, J; Wall, B; Yang, CS | 1 |
| Burgess, B; Chen, YK; Kong, AN; Lee, MJ; Li, G; Lin, Y; Reuhl, K; Shih, WJ; Smolarek, AK; So, JY; Suh, N; Yang, CS | 1 |
2 other study(ies) available for delta-tocopherol and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Differential Gene Regulation and Tumor-Inhibitory Activities of Alpha-, Delta-, and Gamma-Tocopherols in Estrogen-Mediated Mammary Carcinogenesis.
Topics: alpha-Tocopherol; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antioxidants; Apoptosis; Carcinogenesis; Cell Adhesion; Cell Proliferation; Cell Transformation, Neoplastic; Disease Progression; Estrogens; Extracellular Matrix; Female; gamma-Tocopherol; Gene Expression Regulation, Neoplastic; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Neoplasm Metastasis; Neovascularization, Pathologic; Rats; Rats, Inbred ACI; Signal Transduction; Tocopherols | 2017 |
Dietary administration of δ- and γ-tocopherol inhibits tumorigenesis in the animal model of estrogen receptor-positive, but not HER-2 breast cancer.
Topics: Animals; Breast Neoplasms; Carcinoma; Cell Transformation, Neoplastic; Dietary Supplements; Disease Models, Animal; Down-Regulation; Female; gamma-Tocopherol; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Rats; Rats, Sprague-Dawley; Receptor, ErbB-2; Receptors, Estrogen; Tocopherols | 2012 |